SS

Steven Sanders

WL Watson Laboratories: 7 patents #2 of 58Top 4%
WP Watson Pharmaceuticals: 2 patents #10 of 39Top 30%
AB AbbVie: 1 patents #860 of 1,308Top 70%
IM Imec: 1 patents #297 of 687Top 45%
IV Interuniversitair Micro-Electronica Centrum Vzw: 1 patents #167 of 450Top 40%
Overall (All Time): #372,829 of 4,157,543Top 9%
13
Patents All Time

Issued Patents All Time

Showing 1–13 of 13 patents

Patent #TitleCo-InventorsDate
D994832 Hunting tool 2023-08-08
10272061 Compositions and methods for unoccluded transdermal oxybutynin therapy Charles D. Ebert 2019-04-30
8241662 Unoccluded topical oxybutynin gel composition and methods for transdermal oxybutynin therapy Charles D. Ebert 2012-08-14
7687904 Plurality of devices attached by solder bumps Walter De Raedt, Steven Brebels, Tom Torfs, Eric Beyne 2010-03-30
7205177 Methods of bonding two semiconductor devices Walter De Raedt, Steven Brebels, Tom Torfs, Eric Beyne 2007-04-17
7179483 Compositions and methods for transdermal oxybutynin therapy Charles D. Ebert 2007-02-20
7087241 Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy Charles D. Ebert 2006-08-08
7081249 Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy Charles D. Ebert 2006-07-25
7081250 Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy Charles D. Ebert 2006-07-25
7081251 Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy Charles D. Ebert 2006-07-25
7081252 Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy Charles D. Ebert 2006-07-25
7029694 Compositions and methods for transdermal oxybutynin therapy Charles D. Ebert 2006-04-18
6743441 Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy Charles D. Ebert 2004-06-01